title: Hospital-acquired conjunctivitis in a neonatal intensive care unit: Bacterial etiology and susceptibility patterns.
abstract: Our study investigates the causative pathogens of hospital-acquired conjunctivitis in our neonatal intensive care unit and their susceptibility patterns. Coagulase-negative Staphylococcus was the most common bacterium, 22.1% of all isolates. The frequency of the pathogens changed during neonates' stay; Klebsiella pneumoniae (from 18% to 6.9%) and Escherichia coli (from 16% to 4.8%) decreased, whereas methicillin-susceptible Staphylococcus aureus (from 4% to 12.7%) and Enterococcus spp (from 1% to 5.3%) increased. Gram-positive cocci showed high resistant patterns. Our study indicates that the distribution of bacteria causing hospital-acquired conjunctivitis in our neonates shifted from gram-negative to gram-positive microorganisms during their neonatal intensive care unit stay. The resistance patterns are worrisome among gram-positive cocci.
authors.affiliation: Infection Control and Hospital Epidemiology Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. borer07@nir.org.il
authors.forename: Abraham
authors.initials: A
authors.lastname: Borer
authors.forename: Ilana
authors.initials: I
authors.lastname: Livshiz-Riven
authors.forename: Agatha
authors.initials: A
authors.lastname: Golan
authors.forename: Lisa
authors.initials: L
authors.lastname: Saidel-Odes
authors.forename: Ehud
authors.initials: E
authors.lastname: Zmora
authors.forename: Chagit
authors.initials: C
authors.lastname: Raz
authors.forename: Rimma
authors.initials: R
authors.lastname: Melamed
authors.forename: Ygal
authors.initials: Y
authors.lastname: Plakht
authors.forename: Nechama
authors.initials: N
authors.lastname: Peled
mesh_terms: D002175:Candida / Q000302:isolation & purification; D003234:Conjunctivitis, Bacterial / Q000382:microbiology*; D003428:Cross Infection / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000382:microbiology; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D007557:Israel; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000302:isolation & purification; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D012706:Serratia marcescens / Q000187:drug effects / Q000302:isolation & purification; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification